CTNNB1 and gastroesophageal junction adenocarcinoma: Notably, acquired mutation of CTNNB1 may drive immune checkpoint inhibitor (ICI)-acquired resistance in microsatellite instability (MSI)-high esophagogastric adenocarcinoma with BM (71).